Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

186-209 (Activation loop from InterPro)

Target domain

46-328 (Protein kinase domain)

Relief mechanism

Assay

Autoinhibited structure

Activated structure

1 structures for P54665

Entry ID Method Resolution Chain Position Source
AF-P54665-F1 Predicted AlphaFoldDB

No variants for P54665

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for P54665

No associated diseases with P54665

1 regional properties for P54665

Type Name Position InterPro Accession
domain Methyltransferase type 11 43 - 140 IPR013216

Functions

Description
EC Number 2.7.11.22 Protein-serine/threonine kinases
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

3 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
cyclin-dependent protein serine/threonine kinase activity Cyclin-dependent catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
protein serine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate.

1 GO annotations of biological process

Name Definition
protein phosphorylation The process of introducing a phosphate group on to a protein.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MQVQVQEGQT ACDGSLRPLP SAGPASFVPR SLRPAPLRGT STPDRYSRIE KVGEGSYGIV
70 80 90 100 110 120
YKCHDNFTGR TVAMKRIPLI VNDGGVPSTA VREVSLLREL NHPYVVRLLD VVLHEAKLLL
130 140 150 160 170 180
IFEYMEQDLQ GMLKQRNTAF VGGKLRRIMF QLLLGLHECH SRRFVHRDIK PSNILIDRKE
190 200 210 220 230 240
SVVKLADFGL GRAFRVPLQT YTTEVMTLWY RAPEVLLGDK QYLPAVDVWS MGCVFAELAR
250 260 270 280 290 300
RRSLFAGDTA INQLFSIFQL LGTPTEATWR GVTSLPHHNV NFPRWTAKPL RTAVPALDDD
310 320 330 340
GVDLLRRMLC YNPRERITAY EALQHSYFDE VREEEVEKLM RFNGA